Observational, Non-Interventional Study Supporting Validation of eVO2peak Using Results in Patients Receiving Standard of Care Cardiopulmonary Exercise Tests (CPET)
Prolaio · NCT05678530
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 2000
- US sites recruiting
- 11
- Study start
- June 6, 2019
- Record last updated
- September 9, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
In this study, the hypothesis being explored is that peak VO2 and potentially other CPET parameters can be accurately estimated from biosignals (namely, motion from accelerometers and cardiopulmonary variables from EKG) collected during activities of daily living using FDA-cleared wearable biosensors worn by study participants. This study will aim to collect data using wearable biosensors from standard of care patients toward the development of an algorithm that can estimate peak VO2 (eVO2peak) from biosensor data. In addition, this study will explore to further develop other estimated measurements typically reported in CPET, such as VE/VCO2 slope, as well as selected and measures of Left Ventricular Function (diastolic and systolic) typically reported in echocardiogram; instead using wearable biosensors from standard of care testing. A total of 2000 participants will be enrolled including: (Normal) 100 participants, self-reported healthy male and female participants aged 18 to 80 and (Standard of Care) 1900 participants.
Conditions: Cardiopulmonary
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Willing and able to comply with protocol procedures and available for the duration of the study.
- Willing to sign and date informed consent document for study participation.
- Participant is undergoing the Cardiopulmonary Exercise Test (CPET), or an echocardiogram (Echo), or both CPET and Echo as Standard of Care
Exclusion Criteria
- Participant is pregnant, lactating or ≤30 days post-partum.
- Participant has limited or no intrinsic sinus node function (i.e. chronic atrial pacing).
- If participant has an indwelling cardiac device and programming cannot be sufficiently ascertained to assure sinus node competence and lack of atrial pacing, the patient should be excluded.
- Barostim (™) or similar noncardiac electrical pulse generating device in situ.
- Complex congenital heart disease (even repaired or palliated) with the following exception:
- Biventricular physiology without severe valvar dysfunction (e.g. free pulmonary insufficiency) at the discretion of the investigator.
- Any history of allergy to adhesive
- Any cognitive or physical limitations that, in the opinion of the investigator, limits the participant's ability to fully follow study procedures and/or reach a respiratory exchange ratio of 1.0, or perform a maximal CPET in the judgement of the investigator, and/or any limitations pertaining to obtaining a complete Echo
Recruiting US locations
Mayo Clinic Arizona
Scottsdale, AZ 85259
Site contact: Research Technologist · 480-301-6021 · mccoy.rebekah@mayo.edu
VA Palo Alto Healthcare System
Palo Alto, CA 94304
Site contact: Clinical Research Coordinator · 650-493-5000 · jianfu1981@gmail.com
University of California San Francisco
San Francisco, CA 94143
Site contact: Clinical Research Coordinator · 415-476-2060 · Emma.Reagan@ucsf.edu
The Lundquist Institute
Torrance, CA 90502
Site contact: Program Manager · 310-222-2425 · santos.bermejo@lundquist.org
Nemours Cardiac Center
Wilmington, DE 19803
Site contact: Research Program Manager · 302-521-8311 · carol.prospero@nemours.org
Memorial Healthcare System, Office of Human Research
Hollywood, FL 33021
Site contact: Clinical Research Coordinator · 954-265-1849 · PamShaw@mhs.net
Mayo Clinic Florida
Jacksonville, FL 32224
Site contact: Clinical Research Coordinator · (513) 313-7710 · carlisle.ashley@mayo.edu
Mayo Clinic
Rochester, MN 55905
Site contact: Associate Clinical Research Coordinator · 507-422-0541 · sailors.emily@mayo.edu
Baylor Scott & White Research Institute
Dallas, TX 75246
Site contact: Research Enrollment Analyst · (214) 818-7621 · Erin.Lee@bswhealth.org
Baylor Scott & White The Heart Hospital - Plano
Plano, TX 75093
Site contact: Supervisor Clinical Research · 469-814-3524 · shelby.mccoy@bswhealth.org
Intermountain Medical Center
Murray, UT 84107
Site contact: Project Coordinator, Outpatient Pulmonary Research · 801-507-4800 · Stan.Pies@imail.org
Study contacts (from the official record)
- Clinical Trials at Prolaio · 855-869-9054 · hello@prolaio.com
Similar studies in Arizona
All healthy volunteers studies in Arizona →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Developing Biomarkers of Dietary Intake: Dose Dependent Measurement of Sugar Intake
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Location
- Phoenix, AZ
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Phase I Study to Investigate the Effect of Hepatic Impairment of AZD9550 and AZD6234
AstraZeneca
- Location
- Chandler, AZ + 2 other US sites
- Eligibility basics
- Ages 18–85
- RecruitingHealthy volunteersPhase 1
A Phase 1 Relative Bioavailability Study of a VX-581 Tablet Formulation
Vertex Pharmaceuticals Incorporated
- Location
- Tempe, AZ
- Eligibility basics
- Ages 18–55 · Men only
- RecruitingHealthy volunteersPhase 1
A Single and Multiple Ascending Dose Study of EPX-100 in Healthy Adult Participants
Epygenix
- Location
- Tempe, AZ
- Eligibility basics
- Ages 18–55